ASC Therapeutics
ASC Therapeutics develops biopharmaceuticals based on proprietary gene, CRISPR and allogeneic cell therapies
19 employees · est. 2008 · Milpitas, United States
Corrixr Therapeutics
Destroying some of the deadliest squamous cell cancers at their source.
7 employees · est. 2022 · Newark, United States
ASC Therapeutics is the older company (2008 vs 2022); ASC Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | ASC Therapeutics | Corrixr Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2022 |
| Headquarters | ||
| Headquarters | Milpitas, United States | Newark, United States |
| Employees | ||
| Employees | 19 larger | 7 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Seed |
| Total Funding | ||
| Total Funding | Not tracked yet | $6.53M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 2 |
| Services | ||
| Services | Not tracked yet | Development of targeted genetic therapies, Disabling NRF2 in squamous cell cancers, Localized genetic delivery to tumors |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with lung squamous cell carcinoma, Patients with head & neck squamous cell carcinoma, Patients with esophageal squamous cell carcinoma, Oncologists seeking innovative treatments, Healthcare providers specializing in oncology |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Cell Therapy, CRISPR, Blood Disorders, Rare Diseases, Genome Editing, Biopharmaceuticals, Stem Cells, Clinical Research, Biotech Venture, Drug Development | Oncology, Biotherapeutics, Gene Editing, CRISPR/Cas, Pre-clinical Stage, Gene Therapy, Solid Tumors, Clinical Frontier, Therapeutic Platform, Drug-resistant, Innovation, Precision Medicine, Clinical Trials, Oncology Research |
| Website | ||
| Website | asctherapeutics.com | corrixr.com |
About ASC Therapeutics
ASC Therapeutics is a biopharmaceutical company that specializes in the development of gene, CRISPR, and allogeneic cell therapies for rare diseases. The company's focus lies in the development of curative therapies for monogenic blood disorders with high genetic penetrance and conditions requiring...
About Corrixr Therapeutics
CorriXR Therapeutics, founded in 2022, is an emerging force in the biotechnology and health care sectors. Based in the United States, the company is carving out a niche in the development of oncology-focused biotherapeutics through its revolutionary in vivo gene editing platform. The company is uti...
We will tell you when either one moves
BounceWatch watches ASC Therapeutics and Corrixr Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ASC Therapeutics and Corrixr Therapeutics — by email.
Frequently Asked Questions
Compare ASC Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ASC Therapeutics on 16 Nov 2024, and Corrixr Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.